Body weight loss with oral semaglutide is predominantly mediated by effects other than gastrointestinal adverse events Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Meier, J. J.; Agesen, R. M.; Bardtrum, L.; Cheng, A. Y. Y.; Deenadayalan, S.; Montanya, E.; Pratley, R. E.

authors

Publication Date

  • September 1, 2021

webpage

published in

category

start page

  • 237

end page

  • 238

volume

  • 64

issue

  • SUPPL 1